What is the treatment for a subconjunctival hemorrhage?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Subconjunctival Hemorrhage

No specific treatment is required for subconjunctival hemorrhage—it is benign and self-limiting, typically resolving within 1-2 weeks without intervention. 1, 2

Immediate Management

Observation with artificial tears for comfort is the primary management approach. 1 The condition resolves spontaneously as the blood is reabsorbed, and no active intervention accelerates this process. 2

Symptomatic Relief Options

  • Artificial tears can be used to relieve mild irritation or foreign body sensation. 1, 2
  • Cold application may provide comfort when applied for 20-30 minutes per session using ice and water in a bag surrounded by a damp cloth, with a barrier (such as a thin towel) between the cold source and skin to prevent cold injury. 2
  • Patient education about the natural resolution timeline (1-2 weeks) is essential to prevent unnecessary anxiety. 1, 2

Critical Clinical Pitfall: When to Investigate Further

While isolated subconjunctival hemorrhage requires no treatment, recurrent or persistent hemorrhages mandate investigation for underlying systemic conditions. 1, 3

Red Flags Requiring Workup

  • Recurrent hemorrhages warrant systematic evaluation for hypertension, diabetes, bleeding disorders, anticoagulation therapy effects, and rarely, ocular malignancies. 1, 3
  • Salmon-pink conjunctival lesion accompanying hemorrhage suggests possible ocular adnexal lymphoma—this requires biopsy. 1, 4
  • Conjunctival nodules or granulomas warrant biopsy to rule out malignancy. 1
  • Persistent pain or signs of infection require further investigation. 2

The importance of recognizing these warning signs cannot be overstated: ocular adnexal lymphoma can present initially as recurrent subconjunctival hemorrhage. 1, 4

Special Population: Anticoagulated Patients

Anticoagulation therapy does not need to be discontinued for subconjunctival hemorrhage. 1, 2 These hemorrhages are generally considered a minor bleeding risk, are self-limiting, and do not compromise visual acuity. 1, 2 Most bleeds in anticoagulated patients resolve without intervention. 2

For surgical procedures, many surgeons do not routinely stop anticoagulants, though temporary discontinuation may reduce bleeding; consultation with the prescribing physician is advised. 1

Associated Viral Conjunctivitis

When subconjunctival hemorrhage occurs with viral conjunctivitis (check for preauricular lymphadenopathy and follicular reaction), focus management on the underlying viral infection using topical lubricants for comfort, and avoid antibiotics. 1, 2 Antibiotics are ineffective for viral infections. 2

Topical corticosteroids may be considered for severe viral conjunctivitis with marked chemosis, eyelid swelling, or membranous conjunctivitis, but only under close supervision. 2

Follow-up Strategy

  • No follow-up needed for isolated, first-time subconjunctival hemorrhage that resolves as expected. 1
  • Follow-up within 1-2 weeks if symptoms of viral conjunctivitis persist. 1, 2
  • Immediate workup for recurrent cases to identify underlying systemic disease. 1, 3

References

Guideline

Management of Frequent Subconjunctival Hemorrhage

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Subconjunctival Hemorrhage

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Subconjunctival hemorrhage: risk factors and potential indicators.

Clinical ophthalmology (Auckland, N.Z.), 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.